STRS Ohio’s Tempest Therapeutics TPST Stock Holding History

STRS Ohio’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13	Closed	-$16K	–	2089
2019 Q4	$16K	Hold	13	–	–	﹤0.01%	1993
2019 Q3	$17K	Hold	13	–	–	﹤0.01%	1994
2019 Q2	$28K	Buy	+13	New	+$38.3K	﹤0.01%	1998
2015 Q2	–	Sell	-5	Closed	-$527K	–	1937
2015 Q1	$527K	Hold	5	–	–	﹤0.01%	1180
2014 Q4	$601K	Buy	5 +4	+400%	+$293K	﹤0.01%	1135
2014 Q3	$66K	Buy	+1	New	+$35.1K	﹤0.01%	1616
2013 Q4	–	Hold	0	–	-$12K	–	1816
2013 Q3	–	Sell	-1	Closed	-$35.5K	–	1805
2013 Q2	$58K	Buy	+1	New	+$37.6K	﹤0.01%	1719

Other funds holding TPST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

STRS Ohio's TPST Position: Q1 2020 in Review

STRS Ohio sold out of Tempest Therapeutics (TPST) in Q1 2020, closing a stake of 13 shares — an estimated $16K sold.

STRS Ohio first reported a position in TPST in Q2 2013 and held it in 7 quarters. The position peaked at $601K in Q4 2014. 61 funds tracked by Wall St. Rank hold TPST as of Q1 2020.

STRS Ohio reported no remaining Tempest Therapeutics position as of Q1 2020 after selling out during the quarter.
STRS Ohio sold 13 Tempest Therapeutics shares in Q1 2020, an estimated $16K.
STRS Ohio first reported a position in Tempest Therapeutics in Q2 2013 and held it in 7 quarters.
STRS Ohio's Tempest Therapeutics position peaked at $601K in Q4 2014.
61 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2020.

Based on STRS Ohio's 13F filing for Q1 2020, filed 23 Apr 2020.